In this article
The Hooga HG300 occupies what might be the most important position in the red light therapy market: the entry-level panel that actually delivers clinical-grade parameters. In a space where the cheapest devices are often underpowered novelties and the premium options can cost several hundred pounds, the HG300 asks a straightforward question β how much useful light can you get for roughly Β£100?
The answer, as this review details, is surprisingly good.
What You Get
The HG300 is a tabletop LED panel containing 60 dual-chip LEDs arranged in a grid. It is designed to sit on a desk, shelf, or floor stand and deliver red and near-infrared light to a targeted body area from a fixed position.
Physical Specifications
- LED count: 60 dual-chip LEDs (each LED contains both wavelength chips)
- Wavelengths: 660 nm (red) and 850 nm (near-infrared) β delivered simultaneously in a 1:1 ratio
- Panel dimensions: Approximately 30 x 18 x 6 cm
- Weight: Approximately 3.5 kg
- Treatment area: Roughly 30 x 18 cm at the panel surface; effective treatment area approximately 40 x 25 cm at 15 cm distance (accounting for beam spread)
- Power consumption: 60W (actual draw from the wall)
- Cooling: Internal fan (audible but not loud)
- Power source: Mains-powered (AC adaptor included)
- Timer: Built-in timer with 10-minute and 20-minute presets
- Mounting: Included door-hanging bracket; also stands on a flat surface or can be wall-mounted with third-party brackets
Build Quality
The HG300 is built to a budget, and it does not pretend otherwise. The plastic housing is functional rather than premium, the fan produces a noticeable hum, and the overall aesthetic is utilitarian. The door-hanging bracket is a clever solution for hands-free positioning but is not as stable as a wall mount or dedicated stand.
That said, nothing about the build quality compromises the deviceβs function. The LEDs are securely mounted, the wiring is adequate, and the thermal management (fan + aluminium heat sink behind the LED board) keeps the unit at safe operating temperatures during extended sessions.
For a panel in this price range, the build quality is appropriate. You are not paying for premium materials; you are paying for light output.
Irradiance Testing
Irradiance is the single most important specification for any red light therapy device, and it is where the HG300 provides genuine value.
Manufacturer Claims
Hooga states the following irradiance values for the HG300:
- At surface (0 cm): >100 mW/cmΒ²
- At 6 inches (15 cm): >70 mW/cmΒ²
- At 12 inches (30 cm): >30 mW/cmΒ²
Independent Assessment
Third-party irradiance testing of the HG300 by various reviewers (including GembaRed and Alex Fergus) has generally confirmed that the HG300 delivers:
- At surface contact: 80β120 mW/cmΒ² (varies across the panel face β higher at centre, lower at edges)
- At 15 cm: 50β80 mW/cmΒ²
- At 30 cm: 25β40 mW/cmΒ²
These figures are consistent with or slightly below Hoogaβs claims, which is typical for LED panels where manufacturer measurements are taken at the centre of the panel (highest output point) while independent measurements often average across the face.
What These Numbers Mean Practically
At 15 cm treatment distance (the most common positioning for targeted therapy):
- Irradiance: ~60 mW/cmΒ² (average)
- To achieve 6 J/cmΒ² (common therapeutic dose): approximately 100 seconds (1 minute 40 seconds)
- To achieve 10 J/cmΒ²: approximately 167 seconds (2 minutes 47 seconds)
- In a 10-minute session: approximately 36 J/cmΒ² total energy density
- In a 20-minute session: approximately 72 J/cmΒ² total energy density
For most therapeutic applications β pain management, skin rejuvenation, wound healing β the recommended dose range is 4β30 J/cmΒ² per session. The HG300 delivers this range comfortably within 2β10 minutes at typical treatment distances, making the built-in 10-minute timer well-suited for most use cases.
Wavelength Analysis
660 nm (Red)
The 660 nm wavelength is the most extensively studied red wavelength for photobiomodulation. It targets:
- Fibroblast stimulation and collagen production (skin rejuvenation, wound healing)
- Surface-level anti-inflammatory effects
- Superficial musculoskeletal pain
- Skin conditions (acne, psoriasis, dermatitis)
Penetration depth for 660 nm is approximately 4β6 mm into tissue β sufficient for dermal treatment and superficial muscle therapy.
850 nm (Near-Infrared)
The 850 nm wavelength penetrates deeper into tissue (approximately 30β40 mm) and is the primary wavelength for:
- Deep musculoskeletal pain and joint conditions
- Muscle recovery and athletic performance
- Deeper tissue inflammation
- Systemic effects (when treating larger body areas)
The 1:1 Ratio
The HG300 delivers 660 nm and 850 nm simultaneously in equal proportions. Each LED contains both wavelength chips, so the light output is mixed across the entire panel face. This differs from some competitors that arrange red and NIR LEDs in alternating rows, creating slight wavelength distribution variations across the treatment area.
The simultaneous dual-chip approach is preferable for most users because it ensures every point on the treatment surface receives both wavelengths, regardless of how the panel is positioned.
Some users may prefer the ability to switch between red-only and NIR-only modes (available on some competing panels). The HG300 does not offer wavelength switching β both wavelengths are always on simultaneously. For the vast majority of applications, this is perfectly adequate. The only scenario where independent wavelength control offers a meaningful advantage is facial skin treatment where some users prefer red-only to avoid the potential for NIR to slightly increase tissue temperature.
Best Use Cases for the HG300
The HG300βs treatment area (approximately 30 x 18 cm at the panel surface) makes it well-suited for targeted treatment of specific body regions rather than whole-body therapy.
Excellent Use Cases
Facial skin treatment: Position the panel 15β20 cm from the face for 10 minutes. The treatment area covers the full face comfortably. This is one of the most common uses for the HG300 and directly competes with dedicated LED face masks β at a fraction of the cost and with significantly higher irradiance.
Knee and joint pain: Place the panel directly in front of the affected knee at 10β15 cm. The coverage is adequate for a single joint with some surrounding tissue.
Neck and upper trapezius: Position the panel at desk height while seated. The coverage addresses the cervical spine and upper shoulder area effectively.
Forearm, wrist, and hand: The panel size is well-matched to the forearm and hand for conditions like carpal tunnel syndrome, tennis elbow, or wrist tendinopathy.
Wound healing and scar treatment: Position the panel over the affected area at 10β15 cm for targeted treatment.
Adequate Use Cases
Lower back pain: The panel covers approximately half of the lumbar region. For localised lower back pain, this is adequate. For more diffuse back pain, you would need to reposition the panel during the session or invest in a larger unit.
Shoulder treatment: The panel can cover most of the shoulder area from one position, though treating the posterior shoulder requires repositioning.
Insufficient Coverage
Full back treatment: The HG300 is far too small for simultaneous full back coverage. A full-height panel (such as the Mito Red Light MitoPRO series or PlatinumLED BioMax) is the right tool for this purpose.
Whole-body treatment: Not practical. You would need four or more HG300 panels to approximate the coverage of a single full-body unit, and the cost and complexity would exceed that of buying a dedicated full-body panel.
HG300 vs Competing Entry-Level Panels
| Feature | Hooga HG300 | Mito Red Light MitoMIN | Bestqool R300 | Red Light Rising Mini |
|---|---|---|---|---|
| LED count | 60 | 60 | 60 | 60 |
| Wavelengths | 660 + 850 nm | 660 + 850 nm | 660 + 850 nm | 630 + 660 + 830 + 850 nm |
| Irradiance (15 cm) | ~60 mW/cmΒ² | ~60 mW/cmΒ² | ~50β60 mW/cmΒ² | ~60β70 mW/cmΒ² |
| Wavelength switching | No | Yes (R/NIR/both) | No | No |
| Flicker-free | Not verified | Yes (claimed) | Not verified | Yes (claimed) |
| EMF levels | Low (at 15 cm) | Low | Low | Low |
| Approximate UK price | Β£100β130 | Β£200β250 | Β£100β130 | Β£150β200 |
The comparison reveals that the HG300 delivers comparable light output to panels costing nearly twice as much. The Mito Red Light MitoMIN justifies its premium through wavelength switching and verified flicker-free operation, but on pure irradiance per pound spent, the HG300 is difficult to beat.
Strengths
- Exceptional value β clinical-grade irradiance at the lowest price point in the category
- Dual-wavelength (660 + 850 nm) β covers both primary therapeutic windows
- Adequate irradiance (~60 mW/cmΒ² at 15 cm) for efficient treatment sessions
- Built-in timer β practical for consistent dosing
- Compact size β easy to store and position
- Included door-hanging bracket β hands-free positioning without additional purchases
- Established brand with wide availability (Amazon, direct)
Weaknesses
- No wavelength switching β both wavelengths are always on simultaneously
- Plastic housing β functional but not premium
- Fan noise β audible during operation (not disruptive, but noticeable in a quiet room)
- No flicker verification β Hooga does not publish flicker-free certification (though LED panels in this category generally produce minimal flicker)
- Small treatment area β limited to targeted use; cannot replace a full-body panel
- No EMF testing data published by the manufacturer (though third-party testing suggests acceptable levels at recommended treatment distance)
- Basic timer β only preset options (10/20 minutes), no custom timing
- No pulsing modes β continuous wave output only
Who Should Buy the HG300
Ideal for:
- First-time red light therapy users wanting to try PBM without significant financial commitment
- People with specific targeted treatment goals (face, knee, neck, hands)
- Budget-conscious buyers who want legitimate therapeutic parameters
- Students, renters, or anyone with limited space for a large panel
- Those who already have a full-body panel and want a small secondary unit for facial or desk-based use
- Users primarily interested in facial skin rejuvenation (the HG300 outperforms most LED masks on irradiance at a lower price)
Not ideal for:
- Users wanting full-body treatment (buy a half-body or full-body panel)
- Those who want wavelength switching between red-only and NIR-only modes
- Buyers who prioritise premium build quality and aesthetics
- Anyone needing portable, battery-powered therapy (buy a Flexbeam or Kineon)
- Users who want pulsing modes for specific protocols
The Value Proposition
The HG300βs defining characteristic is not any single specification β it is the ratio of therapeutic value to cost. At roughly Β£100β130, it delivers irradiance figures that match or approach panels at twice the price. The wavelengths are the two most evidence-backed in photobiomodulation. The treatment area is sufficient for the most common targeted applications.
Every panel in the entry-level category makes compromises. The HG300βs compromises β no wavelength switching, plastic housing, basic timer β are the right compromises for a budget panel because they do not affect the fundamental therapeutic output. The light that reaches your tissue is comparable to what far more expensive devices deliver.
Verdict
The Hooga HG300 is the best entry-level red light therapy panel on the market by value. It will not win awards for build quality or features, and it cannot replace a full-body panel for whole-body treatment. But for targeted therapy β facial skin, joint pain, neck treatment, wound healing β it delivers clinical-grade parameters at a price that makes red light therapy accessible to anyone willing to try it.
If you are new to red light therapy and unsure whether PBM will benefit you, the HG300 is the panel to buy first. If you discover that red light therapy works for your specific needs, you can upgrade to a larger, full-featured panel later. If it does not, you have risked Β£100 rather than Β£500.
That accessibility, combined with genuine therapeutic output, makes the HG300 the panel we recommend most often for first-time buyers.
Rating: 8/10 β Outstanding value and adequate therapeutic output for targeted use, limited only by its compact size and basic feature set.
This review is editorially independent. Product details and prices were accurate at the time of writing and may change. See our methodology for how we assess devices.
Related topics: hg300 red light therapy device
Find the right device
Compare 20+ red light therapy devices by wavelength, irradiance, and value.
Related articles
Get evidence-based RLT updates
No hype, just research. New studies, protocol updates, and device test results delivered to your inbox.